Breast Cancer

https://www.clatterbridgecc.nhs.uk/download_file/view/15524/2322

Adjuvant

Neoadjuvant

Advanced/Metastatic

Early

Abemaciclib v1.0x
Abemaciclib and Aromatase Inhibitor x
Abemaciclib and Fulvestrant v1.3x
Albumin Paclitaxel (Abraxane) v1.1xxx
Alpelisib (Piqray) and Fulvestrant 2.0x
Atezolizumab/Paclitaxel Albumin (Abraxane) Triple Neg v2.0x
Capecitabine v1.2
x
Carboplatin and Gemcitabine v1.0x
Carboplatin (MBC) v1.0x
Docetaxel and Capecitabine v1.1x
Docetaxel, Trastuzumab, Pertuzumab w/Paclitaxel Alternative HER2 Advanced v 1.1x
Docetaxel, Carboplatin, Trastuzumab neoadjuvant followed by adjuvant Trastuzumab, Pertuzumab (TCHP) v2.3xx
Doxorubicin Weekly v1.1x
Enhertu (Trastuzumab Deruxtecan) HER2 Positive v1.0x
Entrectinib - NTRK Gene Fusion-positive Solid Tumours ROS1-positive v1.1x
Epirubicin Weekly v1.1x
Epirubicin Cyclophosphamide (EC) v1.1x
Epirubicin Cyclophosphamide (EC) v1.1xx
Epirubicin Cyclophosphamide followed by Docetaxel (EC-D) v1.1Xx
Epirubicin Cyclophosphamide followed by Docetaxel w/Trastuzumab (EC-DH) v1.1xx
Epirubicin Cyclophosphamide followed by Docetaxel, Trastuzumab, Pertuzumab (ECD- HP) v2.1xx
Eribulin v2.1x
Everolimus and Exemestane v1.1x
Kadcycla (Trastuzumab Emtansine) v1.3xx
Larotrectinib NTRK Gene Fusion-positive Solid Tumours v1.0x
Neratinib v1.1x
Olaparanib BRCA mutated HER2 negative v1.1x
Paclitaxel Weekly 1.1x
Paclitaxel Weekly v1.3x
Paclitaxel with EC V1.1xx
Paclitaxel with Dose Dense EC v1.3xx
Paclitaxel/Carboplatin with Dose Dense EC v1.1x
Paclitaxel and Gemcitabine v1.1x
Paclitaxel and Trastuzumab v1.2x
Palbociclib v1.2x
Palbociclib and Fulvestrant v1.2x
Pembrolizumab with Carboplatin/Paclitaxel and EC Neoadjuvant followed by Adjuvant Pembrolizumab v1.0xx
Pembrolizumab with Paclitaxel or Nab-paclitaxel as first line treatment triple neg v1.0x
Ribociclib v1.1x
Ribociclib and Fulvestrant v1.1x
Sacituzumab Govitacen Triple Neg (TNBC) v1.1x
Talazoparib with BRCA1/2 Mutation v1.0x
Zoledronic Acid v1.0xx